CRANBURY, N.J.--(BUSINESS WIRE)--OncLive®, the nation’s leading multimedia resource focused on providing oncology professionals with current and insightful information on patient care, is seeking last-call nominations for the 2020 annual Giants of Cancer Care® recognition program, which honors top oncologists and researchers who have made extraordinary advances in oncology research and clinical practice. The window for nominations will officially be closed on February 29.
“We are still accepting nominations for this year’s Giants of Cancer Care® recognition program,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, the parent company of OncLive®. “Every year, we honor leaders in the field of oncology who truly go above and beyond in making strides in cancer research, patient care, and clinical practice.”
The 2020 class will be honored at the eighth annual Giants of Cancer Care® awards reception on May 28 at the Adler Planetarium in Chicago, Illinois. Members of the Giants of Cancer Care® advisory board will select semifinalists from the hundreds of nominations submitted. Afterward, a selection committee comprised of an exclusive group of 115+ oncology experts will vote to determine the 2020 inductees. Nominators are also entered for a chance to win a trip to the reception, including round-trip airfare and a one-night stay at a hotel in Chicago.
Nominations are accepted both internationally and domestically. For more information on the program or to nominate an oncologist, click here.
Supporters of the 2019 program include Athenex, Incyte, Lilly, Ipsen and Mylan.
A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.
About Giants of Cancer Care®
Giants of Cancer Care® celebrates the achievements of leading researchers and educators whose discoveries have helped propel the field of oncology and established the building blocks for future advances. Every year, a selection committee of 115+ eminent oncologists, researchers, and clinicians choose honorees from several different tumor types and specialty categories.